The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease

Blood‐based markers (BBMs) have recently shown promise to revolutionize the diagnostic and prognostic work‐up of Alzheimer's disease (AD), as well as to improve the design of interventional trials. Here we discuss in detail further research needed to be performed before widespread use of BBMs....

Descripción completa

Detalles Bibliográficos
Autores principales: Hansson, Oskar, Edelmayer, Rebecca M., Boxer, Adam L., Carrillo, Maria C., Mielke, Michelle M., Rabinovici, Gil D., Salloway, Stephen, Sperling, Reisa, Zetterberg, Henrik, Teunissen, Charlotte E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087669/
https://www.ncbi.nlm.nih.gov/pubmed/35908251
http://dx.doi.org/10.1002/alz.12756

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087669/
https://www.ncbi.nlm.nih.gov/pubmed/35908251
http://dx.doi.org/10.1002/alz.12756

Ejemplares similares